ATE191615T1 - Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung - Google Patents
Aminosäurenzusammensetzungen und verwendung derselben klinischen nährungInfo
- Publication number
- ATE191615T1 ATE191615T1 AT96904849T AT96904849T ATE191615T1 AT E191615 T1 ATE191615 T1 AT E191615T1 AT 96904849 T AT96904849 T AT 96904849T AT 96904849 T AT96904849 T AT 96904849T AT E191615 T1 ATE191615 T1 AT E191615T1
- Authority
- AT
- Austria
- Prior art keywords
- tnf
- amino acid
- diminution
- levels
- acid compositions
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- 230000035764 nutrition Effects 0.000 title 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 7
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000013632 homeostatic process Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Pediatric Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08392694 US5656608B1 (en) | 1995-02-23 | 1995-02-23 | Amino acid compositions and methods of treatment using same |
| GBGB9512100.0A GB9512100D0 (en) | 1995-06-14 | 1995-06-14 | Improvements in or relating to organic compounds |
| PCT/EP1996/000739 WO1996025861A1 (en) | 1995-02-23 | 1996-02-22 | Amino acid compositions and use thereof in clinical nutrition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE191615T1 true ATE191615T1 (de) | 2000-04-15 |
Family
ID=26307213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96904849T ATE191615T1 (de) | 1995-02-23 | 1996-02-22 | Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0810829B1 (de) |
| JP (1) | JPH11501301A (de) |
| KR (1) | KR19980702436A (de) |
| CN (1) | CN1175887A (de) |
| AT (1) | ATE191615T1 (de) |
| AU (1) | AU710527B2 (de) |
| BR (1) | BR9607336A (de) |
| CA (1) | CA2210499A1 (de) |
| CZ (1) | CZ266797A3 (de) |
| DE (1) | DE69607750T2 (de) |
| DK (1) | DK0810829T3 (de) |
| ES (1) | ES2145997T3 (de) |
| FI (1) | FI972744A (de) |
| HU (1) | HUP9800049A3 (de) |
| NO (1) | NO973884L (de) |
| PL (1) | PL182205B1 (de) |
| PT (1) | PT810829E (de) |
| WO (1) | WO1996025861A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9512100D0 (en) * | 1995-06-14 | 1995-08-09 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| US6096785A (en) * | 1996-07-30 | 2000-08-01 | Novartis Nutrition Ag | Amino acid compositions and use thereof in treating renal dysfunction |
| JP2000515874A (ja) * | 1996-07-30 | 2000-11-28 | ノバルテイス・ニユートリシヨン・アクチエンゲゼルシヤフト | アミノ酸組成物、ならびに腫瘍の成長および転移の処置におけるその使用 |
| GB9701674D0 (en) * | 1997-01-28 | 1997-03-19 | Novartis Nutrition Ag | Use of organic compounds |
| DE69823739T2 (de) * | 1997-06-05 | 2005-04-28 | Novartis Nutrition Ag | Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen |
| CA2298795A1 (en) * | 1997-07-28 | 1999-02-04 | The Institute Of Physical And Chemical Research | Agent for protecting central nerve cells and enhancing survival thereof |
| US6143786A (en) * | 1999-02-02 | 2000-11-07 | Novartis Nutrition Ag | Oral arginine and insulin secretion |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| DK2295081T3 (en) | 2001-06-26 | 2019-02-18 | Amgen Inc | Antibodies to OPGL |
| NL1019368C2 (nl) | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| DE10257360A1 (de) * | 2002-12-09 | 2004-07-08 | Fresenius Kabi Deutschland Gmbh | Gastro-intestinal verabreichbare Formulierung und deren Verwendung |
| WO2005023021A1 (ja) | 2003-09-02 | 2005-03-17 | Bbk Bio Corporation | ダイエット食品 |
| EP1591118A1 (de) | 2004-04-27 | 2005-11-02 | Nutri-Fit GmbH & Co. KG | Verwendung von Melatonin zur Vorbeugung von postoperativen Komplikationen |
| KR100555904B1 (ko) * | 2004-05-19 | 2006-03-03 | 주식회사 오스코텍 | 큰느타리버섯과 오가피의 혼합 생약재 추출물 및 이를유효성분으로 하는 골다공증 예방 및 치료용 조성물 |
| US20100215631A1 (en) * | 2006-06-14 | 2010-08-26 | Anita Hartog | Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof |
| CN105267969A (zh) | 2008-01-04 | 2016-01-27 | 雀巢产品技术援助有限公司 | 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途 |
| US20100179089A1 (en) * | 2009-01-13 | 2010-07-15 | Deutz Nicolaas E P | Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
| NZ615091A (en) * | 2009-06-08 | 2015-03-27 | Ucl Business Plc | Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
| KR101213825B1 (ko) * | 2010-07-16 | 2012-12-18 | 서울대학교산학협력단 | 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물 |
| NZ607189A (en) | 2010-09-24 | 2015-04-24 | Univ Florida | Materials and methods for improving gastrointestinal function |
| WO2014164736A1 (en) | 2013-03-11 | 2014-10-09 | University Of Florida Research Foundation, Incorporated | Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications |
| MX2017006748A (es) | 2014-11-24 | 2017-08-28 | Entrinsic Health Solutions Inc | Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades. |
| WO2017058016A1 (en) * | 2015-10-02 | 2017-04-06 | N.V. Nutricia | Glycine for use in tolerance induction in allergic patients |
| FR3041882B1 (fr) * | 2015-10-06 | 2019-04-12 | Universite D'angers | Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion |
| CA3039514C (en) | 2016-10-04 | 2022-01-25 | University Of Florida Research Foundation, Incorporated | Amino acid compositions and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2591893B1 (fr) * | 1985-12-19 | 1988-11-10 | Centre Nat Rech Scient | Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes |
| US4988724A (en) * | 1988-12-09 | 1991-01-29 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
| EP0663826B1 (de) * | 1991-09-27 | 1998-12-23 | Board Of Regents The University Of Texas System | Parenteral anzuwendende Aminosäuren enthaltende Zubereitungen zur Bekämpfung von Hypotension und verwandten Pathologien |
| US5571783A (en) * | 1993-03-09 | 1996-11-05 | Clintec Nutrition Company | Composition and method for treating patients with hepatic disease |
-
1996
- 1996-02-22 WO PCT/EP1996/000739 patent/WO1996025861A1/en not_active Application Discontinuation
- 1996-02-22 HU HU9800049A patent/HUP9800049A3/hu unknown
- 1996-02-22 KR KR1019970705835A patent/KR19980702436A/ko not_active Application Discontinuation
- 1996-02-22 CN CN96192066A patent/CN1175887A/zh active Pending
- 1996-02-22 PT PT96904849T patent/PT810829E/pt unknown
- 1996-02-22 EP EP96904849A patent/EP0810829B1/de not_active Expired - Lifetime
- 1996-02-22 DK DK96904849T patent/DK0810829T3/da active
- 1996-02-22 CA CA002210499A patent/CA2210499A1/en not_active Abandoned
- 1996-02-22 BR BR9607336A patent/BR9607336A/pt not_active Application Discontinuation
- 1996-02-22 AT AT96904849T patent/ATE191615T1/de not_active IP Right Cessation
- 1996-02-22 DE DE69607750T patent/DE69607750T2/de not_active Expired - Fee Related
- 1996-02-22 ES ES96904849T patent/ES2145997T3/es not_active Expired - Lifetime
- 1996-02-22 JP JP8525404A patent/JPH11501301A/ja active Pending
- 1996-02-22 CZ CZ972667A patent/CZ266797A3/cs unknown
- 1996-02-22 PL PL96321238A patent/PL182205B1/pl unknown
- 1996-02-22 AU AU48795/96A patent/AU710527B2/en not_active Ceased
-
1997
- 1997-06-25 FI FI972744A patent/FI972744A/fi unknown
- 1997-08-22 NO NO973884A patent/NO973884L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR19980702436A (ko) | 1998-07-15 |
| FI972744A (fi) | 1997-08-22 |
| HUP9800049A3 (en) | 1999-01-28 |
| ES2145997T3 (es) | 2000-07-16 |
| BR9607336A (pt) | 1997-11-25 |
| NO973884D0 (no) | 1997-08-22 |
| PL182205B1 (pl) | 2001-11-30 |
| WO1996025861A1 (en) | 1996-08-29 |
| MX9706140A (es) | 1997-11-29 |
| FI972744A0 (fi) | 1997-06-25 |
| DE69607750D1 (de) | 2000-05-18 |
| NO973884L (no) | 1997-10-17 |
| CZ266797A3 (cs) | 1998-03-18 |
| DE69607750T2 (de) | 2000-08-31 |
| PL321238A1 (en) | 1997-11-24 |
| AU4879596A (en) | 1996-09-11 |
| AU710527B2 (en) | 1999-09-23 |
| EP0810829A1 (de) | 1997-12-10 |
| JPH11501301A (ja) | 1999-02-02 |
| CA2210499A1 (en) | 1996-08-29 |
| PT810829E (pt) | 2000-08-31 |
| CN1175887A (zh) | 1998-03-11 |
| DK0810829T3 (da) | 2000-08-28 |
| EP0810829B1 (de) | 2000-04-12 |
| HUP9800049A2 (hu) | 1998-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE191615T1 (de) | Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung | |
| IL112111A (en) | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them | |
| WO2006023665A3 (en) | Il-1 antagonist formulations | |
| AU2002351593A1 (en) | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
| EP0797999A3 (de) | Fettleibigkeitprotein-Formulierungen | |
| DK0619370T3 (da) | Anvendelse af keratinocytvækstfaktor (KGF) til fremstilling af farmaceutiske sammensætninger | |
| DK0758241T3 (da) | Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser | |
| IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
| EP0825197A3 (de) | Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon | |
| MXPA02012064A (es) | Complejos de farmaco macromoleculares y composiciones que los contienen. | |
| HK1030160A1 (en) | Methods of enhancing functioning of the upper gastrointestinal tract | |
| TR199700834T1 (xx) | 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�. | |
| IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
| FR2746098B1 (fr) | Composes propynyl biaromatiques | |
| Wildburger et al. | Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro | |
| EP0821969A3 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
| DE69430416D1 (de) | Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen | |
| DK521389D0 (da) | Praeparat til behandling af adrenoleukodystrofi | |
| Wang et al. | Effects of arginine-devoid diets in chronically uremic rats | |
| WO2004032863A3 (en) | Oral formulations for proteins and polypeptides | |
| DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
| ATE34382T1 (de) | Substituierte dipeptide, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung dieser pharmazeutischen zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |